Friday, January 14, 2022


Kerajaan tetapkan harga siling runcit, borong vaksin Sinovac

Harga siling itu akan berkuat kuasa pada Sabtu ini.

Get booster shot by February or risk vaccination status, says health ministry

Senior citizens and those who have received two doses of Sinovac vaccine must obtain a booster jab in order to maintain their fully vaccinated status.

Pharmaniaga to supply Sinovac booster jabs to designated private centres

It says the vaccine will be made available at selected private hospitals and clinics for those who wish to be given Sinovac as a booster shot.

Conditional approval granted for AstraZeneca, Sinovac jabs as boosters

Health DG Dr Noor Hisham Abdullah says this will apply to those who were initially vaccinated with the same type of jab.

KKM pertimbang suntikan Sinovac, AstraZeneca sebagai dos penggalak

KKM akan umumkan penggunaan kedua-dua jenis vaksin itu selepas Pihak Berkuasa Kawalan Dadah membuat keputusan mengenainya.

Health ministry considering Sinovac, AstraZeneca for booster jabs

An announcement will be made once the Drug Control Authority comes to a decision.

UK to add Sinovac, Sinopharm jabs to list of approved vaccines

The vaccines will be accepted by the UK for inbound travel effective Nov 22.

Indonesia authorises Sinovac Covid-19 vaccine for children aged 6-11

Indonesia had previously cleared the Chinese-made Sinovac vaccine only for people aged 12 and above, of which it has the most amount in its arsenal with over 200 million doses.

WHO advises additional Covid jab for the immunocompromised

The panel also recommends that people over 60 receive an additional dose of the shots made by Chinese vaccine makers Sinopharm and Sinovac some one to three months after completing their schedule.

Drug authority green-lights Sinovac jab for teenagers

This is the second vaccine after the Pfizer shot to be approved for use on adolescents.

Kajian kerajaan dapati Sinovac sangat berkesan untuk perlindungan daripada penyakit serius

Kerajaan berkata vaksinasi tanpa mengira jenama telah mengurangkan risiko kemasukan ke unit rawatan rapi sebanyak 83% dan menurunkan risiko kematian sebanyak 88% berdasarkan kajian membabitkan 1.26 juta penerima vaksin.

Sinovac jab highly effective against serious illness, govt study shows

Rival shots from Pfizer-BioNTech and AstraZeneca show better protection rates although vaccinations regardless of brand have reduced the risk of admission to intensive care by 83% and lowered the risk of death by 88%, according to another study.

Other News